問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taichung Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2025-02-15 - 2028-12-31
Condition/Disease
Test Drug
Participate Sites4Sites
Recruiting4Sites
2017-03-30 - 2025-02-20
Mucopolysaccharidosis type IVA
Vimizim
Participate Sites12Sites
Not yet recruiting8Sites
Recruiting2Sites
Terminated2Sites
2022-04-01 - 2026-06-30
xxxxxx
Participate Sites6Sites
Recruiting6Sites
2019-06-01 - 2025-12-31
Participate Sites3Sites
Recruiting3Sites
2017-11-01 - 2025-02-05
Participate Sites10Sites
Terminated10Sites
2024-12-01 - 2032-12-31
Participate Sites5Sites
Recruiting5Sites
2017-02-10 - 2025-12-31
Terminated1Sites
2023-07-01 - 2028-09-30
Recruiting1Sites
2022-11-01 - 2028-04-30
2023-07-01 - 2029-07-01
Follicular Lymphoma (FL)
Odronextamab
Recruiting12Sites
全部
